Patient data
Liver and kidney dysfunction, RLN injury, voice hoarseness, tumor
TUMOR, EMERGENCY, CARDIOVASCULAR DISEASE, COMPLICATIONS
This study included patients who underwent scheduled Da Vinci robotic thyroidectomy at Fujian Medical University Affiliated Union Hospital from November 24, 2021, to November 30, 2022. All patients are operated on by the same surgeon. The study was approved by the Ethics Committee of Fujian Medical University Affiliated Union Hospital (No. 2021YF051-01) and followed the principles set forth in the Helsinki Declaration and its amendments. The study was registered with the Chinese Clinical Trial Registry (ChiCTR2100054279). All patients have given written informed consent and have been consecutively enrolled in the study. Inclusion criteria: 1. Mallampati grade I-II; 2. Age 18-60 years; 3. Body mass index (BMI) 18-28 kg/m2; 4. ASA grade I-II. Exclusion criteria: 1. Emergency surgery patients; 2. Patients with severe cardiovascular disease; 3. Liver and kidney dysfunction; 4. Suspected difficult airway; 5. Patients with preoperative voice hoarseness or RLN injury or tumor invasion; 6. Patients who changed the surgical method during the operation. Withdrawal criteria: 1. Patients who automatically request termination of the study; 2. Patients with unexpected difficult airways; 3. Patients with RLN injury during surgery; 4. Patients with serious complications during the perioperative period.